[go: up one dir, main page]

FR2626175B1 - Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant - Google Patents

Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant

Info

Publication number
FR2626175B1
FR2626175B1 FR898900705A FR8900705A FR2626175B1 FR 2626175 B1 FR2626175 B1 FR 2626175B1 FR 898900705 A FR898900705 A FR 898900705A FR 8900705 A FR8900705 A FR 8900705A FR 2626175 B1 FR2626175 B1 FR 2626175B1
Authority
FR
France
Prior art keywords
novel
pharmaceutical composition
composition containing
ethylenediamine compounds
ethylenediamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR898900705A
Other languages
English (en)
Other versions
FR2626175A1 (fr
Inventor
Main Brian Geoffrey
Brian Geoffrey Main
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2626175A1 publication Critical patent/FR2626175A1/fr
Application granted granted Critical
Publication of FR2626175B1 publication Critical patent/FR2626175B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR898900705A 1988-01-21 1989-01-20 Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant Expired - Fee Related FR2626175B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888801304A GB8801304D0 (en) 1988-01-21 1988-01-21 Diamine compounds

Publications (2)

Publication Number Publication Date
FR2626175A1 FR2626175A1 (fr) 1989-07-28
FR2626175B1 true FR2626175B1 (fr) 1994-09-30

Family

ID=10630292

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898900705A Expired - Fee Related FR2626175B1 (fr) 1988-01-21 1989-01-20 Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant

Country Status (7)

Country Link
EP (1) EP0325406B1 (fr)
JP (1) JP2656594B2 (fr)
DE (1) DE68911699T2 (fr)
ES (1) ES2061964T3 (fr)
FR (1) FR2626175B1 (fr)
GB (2) GB8801304D0 (fr)
IT (1) IT1232303B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3935371A1 (de) * 1988-12-23 1990-07-05 Merck Patent Gmbh Stickstoffhaltige ringverbindungen
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5804595A (en) * 1995-12-05 1998-09-08 Regents Of The University Of Minnesota Kappa opioid receptor agonists
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6750216B2 (en) 1996-03-08 2004-06-15 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
TNSN97092A1 (ar) 1996-09-18 1999-12-31 Agouron Pharma مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة.
WO1998049158A1 (fr) * 1997-04-30 1998-11-05 Warner-Lambert Company Kappa agonistes opioides peripheriquement selectifs
BR9810706A (pt) * 1997-07-14 2000-08-08 Adolor Corp Processo para a prevenção ou tratamento do prurido em um mamìfero em necessidade de tal prevenção ou tratamento
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
US5965701A (en) * 1997-12-23 1999-10-12 Ferring Bv Kappa receptor opioid peptides
JP2000320371A (ja) 1999-05-10 2000-11-21 Toyota Motor Corp 内燃機関の空燃比制御装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145435A (en) * 1976-11-12 1979-03-20 The Upjohn Company 2-aminocycloaliphatic amide compounds
AT376669B (de) * 1982-11-26 1984-12-27 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thienylessigsaeureamid-derivate und pharmazeutisch vertraeglicher saeureadditionssalze davon
ZA842753B (en) * 1983-05-18 1984-11-28 Upjohn Co 2-dihydropyrrolyl-cycloalkyl-amide analgesics
GB8618188D0 (en) * 1986-07-25 1986-09-03 Ici Plc Diamine compounds
EP0261842B1 (fr) * 1986-09-17 1990-11-22 Dr. Lo. Zambeletti S.p.A. [1-(Phényl- ou benzyl)]-1,2-éthylènediamines N-1-acylées
GB8622352D0 (en) * 1986-09-17 1986-10-22 Zambeleetti Spa Dr L Compounds

Also Published As

Publication number Publication date
JP2656594B2 (ja) 1997-09-24
DE68911699T2 (de) 1994-04-28
GB2214181A (en) 1989-08-31
IT1232303B (it) 1992-01-28
GB2214181B (en) 1991-06-26
ES2061964T3 (es) 1994-12-16
GB8900981D0 (en) 1989-03-08
JPH021439A (ja) 1990-01-05
EP0325406A3 (en) 1990-09-12
EP0325406A2 (fr) 1989-07-26
IT8919116A0 (it) 1989-01-18
FR2626175A1 (fr) 1989-07-28
DE68911699D1 (de) 1994-02-10
EP0325406B1 (fr) 1993-12-29
GB8801304D0 (en) 1988-02-17

Similar Documents

Publication Publication Date Title
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2602974B1 (fr) Composition pharmaceutique contenant de la nicotine ou ses derives
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FR2633182B1 (fr) Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
FR2636948B1 (fr) N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant
FR2645152B1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
FR2626175B1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
FR2523962B1 (fr) Nouveaux amides d'acides aldoniques, leur preparation et compositions les contenant
FR2596651B1 (fr) Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
FR2566773B1 (fr) Nouveaux benzamides substitues, procedes de preparation de ces composes et compositions pharmaceutiques les contenant
FR2527597B1 (fr) Derives d'alcool b,g-dihydropolyprenylique et composition pharmaceutique contenant un compose polyprenylique
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
IL74349A0 (en) (2-oxo-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolinyl)-oxyalkyl amides,their preparation and pharmaceutical compositions containing them
PT86877A (pt) Process for the preparation of a composition for repelling insects and mites containing acylated alpha,omega-aminoalcohol derivatives
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2598617B1 (fr) Composition pharmaceutique
FR2634764B1 (fr) Heterocycles oxaza et compositions pharmaceutiques les contenant
IL91864A0 (en) Pharmaceutical compositions containing 4-bitrophenyl-dihydropyridine amides,certain such novel compounds and their preparation
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
ST Notification of lapse